Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.730
+0.030 (1.76%)
At close: Oct 9, 2025
BIT:ERFO Revenue
Laboratorio Farmaceutico Erfo had revenue of 5.06M EUR in the half year ending June 30, 2025, with 53.11% growth. This brings the company's revenue in the last twelve months to 7.90M, up 35.66% year-over-year. In the year 2024, Laboratorio Farmaceutico Erfo had annual revenue of 6.03M with 1.69% growth.
Revenue (ttm)
7.90M
Revenue Growth
+35.66%
P/S Ratio
1.82
Revenue / Employee
168.06K
Employees
41
Market Cap
14.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.03M | 100.36K | 1.69% |
| Dec 31, 2023 | 5.93M | 1.21M | 25.70% |
| Dec 31, 2022 | 4.72M | -287.57K | -5.74% |
| Dec 31, 2021 | 5.01M | 972.01K | 24.09% |
| Dec 31, 2020 | 4.03M | -535.30K | -11.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Davide Campari-Milano | 3.07B |
| Italmobiliare | 731.93M |
| Intercos | 1.09B |
| B.F. S.p.A. | 1.60B |
| NewPrinces | 2.59B |
| MARR S.p.A. | 2.04B |
| Orsero | 1.67B |
| Fine Foods & Pharmaceuticals N.T.M. | 250.25M |